icon-folder.gif   Conference Reports for NATAP  
  The Liver Meeting
San Francisco
November 2018
Back grey_arrow_rt.gif
Association Between Apolipoprotein C3 and Serum Triglycerides in Nonalcoholic Steatohepatitis Patients Treated With the Acetyl-CoA Carboxylase Inhibitor GS-0976
  Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
Parvez Mantry,1 Zeid Kayali,2 Mazen Noureddin,3 Peter J. Ruane,4 Bryan J. McColgan,5 Jacqueline M. Tarrant,5 Lulu Wang,5 Tuan Nguyen,5 Eliza Harting,5 Chuhan Chung,5 Robert P. Myers,5 Scott D. Patterson,5 Michelle Lai,6 Michael Charlton,7 Eric J. Lawitz,8 Stephen A. Harrison,9 Rohit Loomba10
1The Liver Institute at Methodist Dallas, TX; 2Inland Empire Liver Foundation, Rialto, CA; 3Cedars-Sinai Medical Center, Los Angeles, CA; 4Ruane Clinical Research Group, Inc., Los Angeles, CA; 5Gilead Sciences, Inc., Foster City, CA; 6Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; 7University of Chicago, IL; 8Texas Liver Institute, UT Health San Antonio, TX; 9Pinnacle Research, San Antonio, TX; 10UC San Diego, La Jolla, CA